Skip to main content
. 2019 Apr 29;45(2):51–67. doi: 10.5125/jkaoms.2019.45.2.51

Table 2. Dental bone graft substitutes which Food and Drug Administration (FDA) 510(k) approved.

Product name Approved date (mo/day/yr) Indications with FDA 510(k) approved
Cerasorb M granules 7/22/2005 Alveolar augmentation
Filling of defects after root resection, apicoectomy, and cystectomy
Filling of extraction sockets
Elevation of the maxillary sinus floor
Filling of periodontal/perio-implant defects for GTR and GBR
MBCP 12/11/2003 Bone void filler for bony voids or gaps of the skeletal system
Used with autograft as a bone graft extender
Osseous defects and/or from traumatic injury to the bone.
Without initial mechanical properties. Therefore, rigid fixation techniques may often be recommended. Gradually resorbs and is replaced with bone.
MBCP Plus, MBCP+ 7/30/2007 Periodontal/infrabony defects
Ridge augmentation
Extraction site (for implant)
Sinus graft and cyst defect
OSTEON 7/8/2010 Periodontal/infrabony defects
Ridge augmentation
Extraction site (for implant)
Sinus lifts
Cystic cavities
OSTEON II 12/26/2011 Periodontal/infrabony defects
Ridge augmentation
Extraction site (implant preparation/placement)
Sinus lifts
Cystic cavities
OSTEON III 9/14/2016 Periodontal/infrabony defects
Ridge augmentation
Extraction site (implant preparation/placement)
Sinus lifts
Cystic cavities
TCP Dental 11/10/2004 Cystic cavities
Packed into bony voids or gaps of the skeletal system (such as the extremities, spine and the pelvis).
Osseous defects and/or from traumatic injury to the bone.
Resorbs and is replaced with bone during the healing process.
-Approved for KASIOS TCP not (KASIOS) TCP Dental

(GTR: guided tissue regeneration, GBR: guided bone regeneration)